Key Points
- Oracle Vice Chairman Jeffrey Henley sold 400,000 shares on June 24 at an average price of $159.16, for a total of $63.66 million. The sale was made under a pre-arranged Rule 10b5-1 trading plan.
- After the transaction, Henley still owned 400,000 shares, meaning his stake fell by 50%. The filing was disclosed with the SEC.
- Oracle recently beat earnings expectations, reporting $2.11 EPS versus the $1.96 estimate and revenue of $19.18 billion, up 20.6% year over year. The company also pays a quarterly dividend of $0.50 per share, or $2.00 annually.
Oracle Corporation (NYSE:ORCL - Get Free Report) Vice Chairman Jeffrey Henley sold 400,000 shares of Oracle stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $159.16, for a total value of $63,664,000.00. Following the transaction, the insider owned 400,000 shares of the company's stock, valued at $63,664,000. This represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Oracle Price Performance
Shares of NYSE:ORCL opened at $148.68 on Friday. The business's fifty day moving average price is $189.53 and its two-hundred day moving average price is $175.69. The stock has a market cap of $428.27 billion, a PE ratio of 25.50, a price-to-earnings-growth ratio of 0.96 and a beta of 1.65. The company has a debt-to-equity ratio of 3.21, a quick ratio of 1.35 and a current ratio of 1.12. Oracle Corporation has a one year low of $134.57 and a one year high of $345.72.
Oracle (NYSE:ORCL - Get Free Report) last released its quarterly earnings results on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.96 by $0.15. Oracle had a return on equity of 58.62% and a net margin of 25.37%.The company had revenue of $19.18 billion during the quarter, compared to the consensus estimate of $19.10 billion. During the same quarter last year, the business posted $1.70 earnings per share. Oracle's revenue was up 20.6% compared to the same quarter last year. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. On average, analysts forecast that Oracle Corporation will post 6.45 EPS for the current fiscal year.
Oracle Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 24th. Investors of record on Friday, July 10th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Friday, July 10th. Oracle's dividend payout ratio (DPR) is currently 34.31%.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of ORCL. HFM Investment Advisors LLC increased its position in shares of Oracle by 290.9% in the fourth quarter. HFM Investment Advisors LLC now owns 129 shares of the enterprise software provider's stock worth $25,000 after acquiring an additional 96 shares in the last quarter. Basepoint Wealth LLC acquired a new position in shares of Oracle during the 4th quarter valued at $26,000. FSA Wealth Management LLC acquired a new position in shares of Oracle during the 3rd quarter valued at $28,000. Osbon Capital Management LLC purchased a new stake in Oracle during the 4th quarter worth $28,000. Finally, Joseph Group Capital Management purchased a new stake in Oracle during the 4th quarter worth $29,000. Hedge funds and other institutional investors own 42.44% of the company's stock.
Analysts Set New Price Targets
Several research firms have issued reports on ORCL. Piper Sandler raised their price target on shares of Oracle from $210.00 to $225.00 and gave the stock an "overweight" rating in a research note on Thursday, June 11th. Guggenheim reissued a "buy" rating and set a $400.00 price objective on shares of Oracle in a research note on Thursday, June 11th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Oracle from $375.00 to $300.00 and set a "buy" rating on the stock in a research report on Monday, March 9th. UBS Group lifted their target price on shares of Oracle from $250.00 to $285.00 and gave the stock a "buy" rating in a research note on Tuesday, June 2nd. Finally, KeyCorp reiterated an "overweight" rating on shares of Oracle in a report on Thursday, June 11th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $268.27.
Get Our Latest Stock Analysis on Oracle
Oracle News Roundup
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle Health and Theator announced an AI-powered surgical reporting partnership, adding another real-world use case for Oracle Cloud Infrastructure in healthcare. Oracle Health (ORCL), Theator Partner to Automate Surgical Reporting with AI
- Positive Sentiment: Several recent articles highlighted Oracle’s massive contract backlog and strong AI cloud demand, arguing the company has improved long-term revenue visibility despite near-term volatility. Oracle's Contract Backlog Swells: Is Long-Term Revenue Growth Secured?
- Positive Sentiment: Wall Street sentiment remains broadly constructive, with coverage pointing to dozens of buy ratings and meaningful upside from current levels. Oracle stock has worst week since 2001 dot-com bust as AI financing concerns escalate
- Neutral Sentiment: Oracle was also featured in commentary suggesting the recent sell-off may be overdone and more a valuation/mispricing issue than a fundamental break in the AI story. Oracle's Market Disconnect: The Truth Can Make You Rich
- Negative Sentiment: Investor concern is centered on Oracle’s aggressive AI spending: capital expenditures surged, free cash flow turned deeply negative, and debt is now high, raising questions about financing the buildout. Oracle stock has worst week since 2001 dot-com bust as AI financing concerns escalate
- Negative Sentiment: OpenAI IPO delay fears weighed on Oracle and other AI-related stocks, since Oracle is tied to the broader AI infrastructure trade. OpenAI May Push Back Highly-Awaited IPO to 2027, Slamming SoftBank and Oracle Shares
- Negative Sentiment: Oracle Vice Chairman Jeffrey Henley sold 400,000 shares in a pre-arranged 10b5-1 plan, a headline that can add to sentiment pressure even if the sale was scheduled. SEC filing for Jeffrey Henley stock sale
About Oracle
(
Get Free Report)
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle's product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
